Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Cash from Financing Activities (2018 - 2024)

Historic Cash from Financing Activities for CollPlant Biotechnologies (CLGN) over the last 7 years, with Q1 2024 value amounting to $9000.0.

  • CollPlant Biotechnologies' Cash from Financing Activities fell 9887.92% to $9000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $9000.0, marking a year-over-year decrease of 9918.77%. This contributed to the annual value of $9000.0 for FY2024, which is 9918.77% down from last year.
  • As of Q1 2024, CollPlant Biotechnologies' Cash from Financing Activities stood at $9000.0, which was down 9887.92% from $216000.0 recorded in Q3 2023.
  • In the past 5 years, CollPlant Biotechnologies' Cash from Financing Activities ranged from a high of $35.5 million in Q1 2021 and a low of -$54000.0 during Q2 2020
  • Moreover, its 5-year median value for Cash from Financing Activities was $308000.0 (2022), whereas its average is $3.3 million.
  • Examining YoY changes over the last 5 years, CollPlant Biotechnologies' Cash from Financing Activities showed a top increase of 2157142.86% in 2020 and a maximum decrease of 190000.0% in 2020.
  • Over the past 5 years, CollPlant Biotechnologies' Cash from Financing Activities (Quarter) stood at -$6000.0 in 2020, then skyrocketed by 2466.67% to $142000.0 in 2021, then soared by 181.69% to $400000.0 in 2022, then crashed by 46.0% to $216000.0 in 2023, then crashed by 95.83% to $9000.0 in 2024.
  • Its last three reported values are $9000.0 in Q1 2024, $216000.0 for Q3 2023, and $89000.0 during Q2 2023.